Genomic Health Inc. (GHDX) PT Raised to $64 at Piper Jaffray
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
3 Buy, 15 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Piper Jaffray analyst William Quirk raised the price target on Genomic Health Inc. (NASDAQ: GHDX) to $64.00 (from $60.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Golar LNG Ltd. (GLNG) PT Raised to $70 at BTIG
- Asia Vital Components Co Ltd (3017:TT) PT Raised to NT$4,250 at Macquarie
- Galaxy Entertainment Group Ltd (27:HK) (GXYEF) PT Lowered to HK$43.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
